Skip to main content
Premium Trial:

Request an Annual Quote

Bio-Rad Hits 52-Week High; Stratagene Leads Index

Shares in Bio-Rad Laboratories hit a 52-week high this week, closing Monday at $80.42, up 2.4 percent for the trading period ended Monday — a day earlier than normal due to the Thanksgiving holiday in the US this week. Stratagene led all gainers in the BCW Index with a 7.5 percent jump for the week. Qiagen led decliners for the week with a drop of 4.9 percent.
 
Overall, the Index gained 0.7 percent for the week, lagging the Nasdaq Biotech Index, which gained 1.5 percent; the broader Nasdaq market, which rose 0.9 percent; and the Dow Jones Industrial Average, which climbed 0.8 percent.
 
 
BioCommerce Week Index of Diversified
Molecular Biology Tool Companies
Company
Ticker
Current Price
(November 20, 2006)
Last
Price
(November 14, 2006)
% change
Agilent A
33.74
33.00
2.2
Applied Biosystems ABI
36.81
37.57
-2.0
Beckman BEC
59.92
59.75
0.3
Bio-Rad BIO
80.42
78.52
2.4
Bruker BRKR
7.91
8.00
-1.1
GE GE
35.98
35.59
1.1
Invitrogen IVGN
57.24
57.09
0.3
Millipore MIL
68.64
66.41
3.4
Molecular Devices MDCC
21.39
20.73
3.2
PerkinElmer PKI
21.51
21.64
-0.6
Qiagen QGEN
14.83
15.60
-4.9
Sigma SIAL
76.97
77.42
-0.6
Stratagene STGN
7.21
6.71
7.5
Thermo TMO
43.84
43.71
0.3
Waters WAT
50.74
51.04
-0.6
BCW Index Average  
41.14
40.85
0.7

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.